MedTrace Logo

Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee

NCT00604539 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2011-12-19

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a chondroitin sulphate conventional treatment on the degree of severity of synovitis, as measured by magnetic resonance in patients with knee OA with clinical synovitis.

Conditions

Interventions

DRUG

Chondroitin sulphate (Condrosan)

800 mg (two capsules of 400 mg each) taken once a day for one year

DRUG

Placebo

Two placebo capsules taken once a day for six months followed by an additional six month treatment of 800 mg (two capsules of 400 mg of Chondroitin sulphate each) taken once a day

Sponsors & Collaborators

  • Bioiberica

    lead INDUSTRY

Principal Investigators

  • Jean-Pierre Pelletier, Prof., Dr. · ArthroLab Inc.

  • Johanne Martel-Pelletier, Prof., Dr. · ArthroLab Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00604539 on ClinicalTrials.gov